RR
Ruchi Rani
About Ruchi Rani
Data last updated:
Ruchi Rani is a Director at R2r Manufacturing And Trading Private Limited (since 2021) and Director at Medirose Drugs And Pharmaceuticals Private Limited (since 2024). The companies operate in Food and Beverages and Paper. The largest current company by reported revenue is R2r Manufacturing And Trading Private Limited at ₹250 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Feb 2021 | 2021 | ₹250 Cr (FY 2025) | Active | |
| Director | 21 Feb 2024 | 2024 | Active |
Board colleagues of Ruchi Rani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Baljeet Kaur | R2r Manufacturing And Trading Private Limited | Company Secretary | |
| Rajesh Kumar Soni | 09070833 | R2r Manufacturing And Trading Private Limited , Medirose Drugs And Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ruchi Rani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ruchi Rani
Ruchi Rani currently holds 2 directorships: R2r Manufacturing And Trading Private Limited (Director, since 17 Feb 2021, revenue ₹250 Cr (FY 2025)); Medirose Drugs And Pharmaceuticals Private Limited (Director, since 21 Feb 2024).
Ruchi Rani was first appointed on 17 Feb 2021 as Director at R2r Manufacturing And Trading Private Limited. The most recent appointment on record is 21 Feb 2024 at Medirose Drugs And Pharmaceuticals Private Limited.
The current boards of Ruchi Rani's companies include Baljeet Kaur (R2r Manufacturing And Trading Private Limited), Rajesh Kumar Soni (R2r Manufacturing And Trading Private Limited).